China Pharmaceutical Market Analysis, 2010-2014
- ID: 1295159
- August 2010
- Region: China
- 58 pages
- Venn Research Inc
Having displayed very high growth rates in the years 2005-2008 the China pharmaceuticals market is expected to decelerate significantly in 2009 followed by the slow and constant decrease in growth in the years up to 2014.
The China pharmaceuticals market generated total revenues of $23,796.9 million in 2009, representing a compound annual growth rate (CAGR) of 20.1% for the period spanning 2005-2009. In comparison, the Japanese and Indian markets grew with CAGRs of 2.3% and 11.3% respectively, over the same period, to reach respective values of $66,889.3 million and $10,838.7 million in 2009.
Alimentary/metabolism sales proved the most lucrative for the China pharmaceuticals market in 2009, generating total revenues of $2,426.7 million, equivalent to 10.2% of the market's overall value. In comparison, cardiovascular sales generated revenues of $2,208.9 million in 2009, equating to 9.3% of the market's aggregate revenues.
This report highlights the China pharmaceutical sector in terms of market share, key trends, market players and competitive scenario in the market.
- Current market scenario of China pharmaceutical market, by revenue, geographic regions, product types, and market players.
- Competitive analysis of the pharmaceutical sector by each country via-a-vis global market
- Market forecast of China Pharmaceuticals market, by revenue till 2014.
- Covered more than 9 company profiles in the pharmaceutical sector covering their performance, key financials, SWOT analysis, and investment analysis.
Venn Research, in association to its network of partners provides information and research to thousands of clients worldwide. The information provided herein has been obtained from reliable sources to provide a holistic survey on the market dynamics.
SHOW LESS READ MORE >
1 China Pharmaceuticals Market, 2010
1.1 Quick Glance at the Market
1.2 Market Scenario
2 China Pharmaceuticals Market, By Categories, 2010
3 China Pharmaceuticals Market, By Market Players, 2010
4 China Pharmaceuticals Market Outlook, 2011-2014
5 China Pharmaceuticals Market - Competitive Analysis
6 Company Profiles
6.1 Astellas Pharma
6.1.1 Key Financials
6.1.4 Products And Services Analysis:
6.1.5 SWOT Analysis
6.1.6 Company View
6.2 Daiichi Sankyo Co., Ltd.
6.2.1 Key Financials
6.2.4 Products and Services Analysis
6.2.5 Competitor Analysis
6.2.6 SWOT Analysis
6.3 Pfizer Inc
6.3.1 Key Financials
6.3.4 Products and Services Analysis
6.3.5 Competitor Analysis
6.3.6 SWOT Analysis
6.4 Jiangsu Yangtze River Pharmaceutical Group
6.5 Yung Shin Pharmaceutical Industry Co., Ltd.
6.6 ScinoPharm Taiwan, LTD.
6.6.2 Competitors Analysis
6.7 Cipla Ltd
6.7.3 Competitor Analysis
6.8 Piramal Healthcare (PHL)
6.8.3 Competitor Analysis
6.8.4 Investment Analysis
6.9 Ranbaxy Laboratories Limited
6.9.3 Products and Services Analysis
6.9.4 Competitor Analysis
6.9.5 SWOT Analysis
List of Tables:
Table 1: China Pharmaceuticals Market, ($billions) 2005-2010
Table 2: China Pharmaceuticals Market, By Categories, 2010
Table 3: China Pharmaceuticals Market, By Market Players, 2010
Table 4: China Pharmaceuticals Market Outlook, ($billions) 2011-2014
Table 5: Astellas Pharma - Key Financials, 2008-2010
Table 6: Astellas Pharma - Historical Stock Information
Table 7: Astellas Pharma Sales, By Geography
Table 8: Astellas Pharma Sales, By Products
Table 9: Daiichi Sankyo Co., Ltd. - Key Financials
Table 10: Daiichi Sankyo Co., Ltd. Sales, By Geography
Table 11: Pfizer Inc - Key Financials, 2007-09
Table 12: Pfizer Inc - Historical Stock Information
Table 13: Pfizer Inc Sales, By Products and Services, 2009
Table 14: Pfizer Inc Sales, By Geography, 2009
Table 15: Jiangsu Yangtze River Pharmaceutical Group - Key Financials
Table 16: Yung Shin Pharmaceutical Industry Co., Ltd. - Key Financials
Table 17: Cipla Ltd Sales, By Geography
Table 18: Piramal Healthcare Limited, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2010
Table 19: Piramal Healthcare Limited, Pharmaceuticals & Healthcare Deals By Type, 2005 to YTD 2010
Table 20: Ranbaxy Laboratories Limited Sles, By Georaphy, 2008
List of Figures:
Figure 1: China Pharmaceuticals Market, ($billions) 2005-2010
Figure 2: China Pharmaceuticals Market, By Categories, 2010
Figure 3: China Pharmaceuticals Market, By Market Players, 2010
Figure 4: China Pharmaceuticals Market Outlook, ($billions) 2011-2014
Daiichi Sankyo Co., Ltd.
Jiangsu Yangtze River Pharmaceutical Group
Yung Shin Pharmaceutical Industry Co., Ltd.
ScinoPharm Taiwan, LTD.
Ranbaxy Laboratories Limited
Piramal Healthcare (PHL)